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Abstract
Background and Objective: This study evaluates whether Computer Tomography is an effective procedure for
preoperative staging of patients with Peritoneal Carcinomatosis.
Method: A sample of 37 patients was analyzed with contrast enhanced abdominal Computer Tomography,
followed by surgical staging. All Computer Tomography scans were evaluated 3 times by 2 radiologists with one
radiologist reviewing 2 times. The efficacy of Computer Tomography was evaluated using the Spearman correlation
coefficient. Correlations were analyzed by abdominopelvic region to assess results of the Peritoneal Carcinomatosis
Index (PCI) aggregating the 13 regions. Surgical findings were compared to radiological findings.
Results: Results indicate high correlations between the surgical and radiological Peritoneal Carcinomatosis Indices.
Analyses of the intra-class correlation between the first and second reading of one radiologist suggest high intra-
observer reliability. Correlations by abdominopelvic region show higher values in the upper and middle regions
and relatively lower values in the lower regions and the small bowel (correlation coefficients range between 0.418
and 0.726, p < 0.010; sensitivities range between 50% and 96%; and specificities range between 62% and 100%).
Conclusion: Computer Tomography represents an effective procedure in the preoperative staging of patients with
PC. However, results by abdominopelvic region show lower correlation, therefore suggest lower efficacy. These
results are supported by analyses of sensitivity and accuracy by lesion size. This suggests that Computer
Tomography is an effective procedure for pre-operative staging but less for determining a tumor’s accurate extent.
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Introduction
Peritoneal Carcinomatosis ("PC”) is a common metasta-
sis location for many tumor variances with high inci-
dences occurring in ovarian, gastric, and colorectal
cancers. In literature, the occurrence frequencies for
peritoneal metastases in ovarian, gastric, and colorectal
cancers amount to 71%, 17%, and 10%, respectively
[1,2]. Due to its natural history, PC is commonly asso-
ciated with weak prognosis [3].
Today, various therapeutic procedures for PC exist
with treatments being dependent on the PC’s location
and extent. The existence of peritoneal disease leads to
different therapeutic procedures including exclusive use
of systemic chemotherapy, cytoreductive surgery com-
bined with or without hyperthermic intra-abdominal
intra-peritoneal chemotherapy or exclusive palliative
management. In order to achieve a highly selective
group of patients a wide array of complex therapeutic
procedures constitutes the current state of clinical
research, including curative focused cytoreductive sur-
gery ("CS”) and hyperthermic intraperitoneal chemoper-
fusion ("HIPEC”) [4-12].
Elias et al. demonstrated a median survival of 5 years
with a 51% survival rate which is achieved by applying
the HIPEC approach in a sample of well selected
patients with PC of colorectal origin [13]. To ensure
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mandatory to apply this treatment on patients with lim-
ited peritoneal disease where a complete cytoreduction
can be achieved. Contrast enhanced abdominopelvic
computed tomography ("CT”) is a frequently used pre-
operative radiologic imaging modality to diagnose can-
cer within the abdominal cavity [3]. In former research
the efficacy of CT diagnosing PC is not well established
with an unknown size of implants being detected reli-
ably [14]. Earlier work on CT of peritoneal malignancy
was devoted to the detection of disease [15-19].
More recent studies analyzing the size of implants
record varying sensitivities of 63% to 90% and specifici-
ties of up to 100% for the diagnosis of peritoneal metas-
tasis [3]. However, in further work, sensitivities range
from 41% to 79% and specificities are observed of up to
100% [20-22].
In a recent study by Coakley et al. ovarian carcinoma-
tosis has been detected at relatively higher sensitivities
of 85% to 93% [3]. Results were obtained with single-
row CT scanners. The multi-row detector CT (MDCT)
technology following the single-row CT scanner tech-
nology was able to show improved sensitivities and
shortened examination time by allowing the generation
of thin slices with subsequent multi-planar reconstruc-
tion (MPR). This technology was able to extents and
metastatic spreads in patients with various malignancies
as better imaging results were achieved through
improved illustration of peritoneal implants. Calculated
sensitivities are dependent on the lesion size ("LS”)a n d
are relatively weak for small lesion sizes; for example,
sensitivities for lesions of less than 1 cm were observed
between 20% and 25% resulting in low reliability of diag-
nosis quality [3,20,22].
A commonly applied regime for the quantification of
the extent of PC and its deposits is the Peritoneal Can-
cer Index ("PCI”) developed by Sugarbaker [23]. Today
the PCI is acknowledged by research and used for deter-
mining therapeutic measures. It serves as an indepen-
dent prognostic indicator for long-term outcomes in PC.
The PCI is calculated as the sum of numerical lesion
scores assigned to 13 abdominopelvic regions. The
lesion score relates to the largest visible tumor deposit.
The objective of this study is to analyze the appropri-
ateness and accuracy of CT as pre-operative diagnostic
procedure and in combination with PCI as its indicator
in detecting and determining the size and extent of PC.
Materials and methods
Three individual readers of two radiologists and one
surgeon evaluated pre-operative contrast enhanced
abdominal CT scans for a population of 37 patients.
Patients in the population underwent explorative
laparotomy and were suspected to have PC from pri-
mary solid tumors.
Tumor spread, localization and size were described
a n dd o c u m e n t e da p p l y i n gS u g a r b a k e r ’s PCI and lesion
size schemes in both, radiological as well as surgical
investigations. Radiological observations were retrospec-
tively compared to surgical observations, whereby surgi-
cal findings were regarded as the Gold Standard.
Radiological findings were then statistically analyzed
using correlation analyses including inter-observer as
well as intra-observer reliability analyses.
CT protocol
All patients underwent CT scans according to a standar-
dized CT acquisition protocol. Contrast enhancements
were used including an oral contrast agent and the rec-
tal filling Gastrolux (Sanochemia Diagnostics, Germany).
All patients received intravenous injections of 110 mL
Iomeprol (Imeron 300, Bracco Imaging, Germany) with
a flow rate of 3 mL/s. A multi-slice CT scan (Siemens
Somatotom Sensation 64, Germany) was used and all
scans were conducted at 120 kV with 220 mAs as well
as applying a care dose. Subsequent CT scans were
started with a delay of 70 seconds. The collimation was
0.6 mm and the slice thickness was 5 mm, including
coronal and sagittal reformations.
Patient population
In this study a sample of 37 patients was investigated.
Within this population 23 female and 14 male patients
were between 24 and 78 years with an average age of 66
years at the time of the CT scan. All patients have
shown solid primary tumors and underwent primary
tumor surgery shortly after the CT scan (no more than
4 weeks).
In this population 32 patients had PC and 5 no PC; no
patients were excluded from the study. The median time
between CT scan and surgery was 10 days. Out of the
37 patients, 7 had colon cancer, 6 had gastric cancer, 5
had pseudomyxoma peritonei, 5 had ovarial cancer, 4
had pancreatic cancer, 3 had cancer of unknown pri-
mary, 2 had appendiceal cancer, and one patient each
had adenocarcinoma of the abdominal wall, malignant
mesenterial mesothelioma, gastrointestinal stomal
tumor, mammary carcinoma, and pleural mesothelioma.
System of tumor determination and description of PCI
and LS score
The PCI is an accepted score for the quantification of
tumor spread and localization. It serves as an indicator
for therapy planning and prognosis. The entire abdom-
inal and intestinal region is divided into 13 regions (Fig-
ure 1).
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size is measured and assigned to a lesion size score
between LS = 0 and LS = 3. LS = 0 means no tumor
visible, LS = 1 means a tumor lesion size below 0.5 cm,
LS = 2 means a tumor lesion size between 0.5 cm and 5
cm, and LS = 3 means a tumor lesion size larger than 5
cm or describes a confluent tumor.
LS scores in the individual regions are summed up to
the PCI score which can assume a minimum score of 0
and a maximum score of 39.
The PCI is a semi-quantitative indicator for the deter-
mination of the extent of spread of peritoneal tumor.
The success of complete cytoreductive surgery and
prognosis of the patient correlates with the PCI. Patients
with PC of colorectal origin with a reported PCI score
of less than or equal to 10 have a 5 year survival rate of
50%; and lower survival rates of 20% and 0% for PCI
scores between 11 and 20, and over 20, respectively.
Radiological analyses
CT scans were conducted before explorative laparotomy
with CT results being compared to intra-operative find-
ings. In total, all CT scans were evaluated three times
independently with some time-lag between each evalua-
tion reading. Two radiological senior physicians with 20
years of experience evaluated the PCI scores indepen-
dently from each other to achieve inter-observer reliabil-
ity. Radiologist 1 reviewed scans twice to achieve intra-
observer reliability, whereas Radiologist 2 only reviewed
once. In order to obtain unbiased results evaluating
radiologists were neither informed about the status of
primary tumor nor the PC. In addition, a control group
of 5 patients was added to the study that did not show
PC in the explorative laparotomy.
Surgical analyses
The explorative laparotomy and intra-operative data
evaluations were conducted by a surgical team of one
surgeon following a standard procedure and protocol.
All patients underwent surgery in the same institution.
Surgical and pathological findings were evaluated pro-
spectively and documented.
In particular, the PCI score assignment was conducted
by a surgical senior physician with 11 years experience
in PC surgery. Intra-operative results regarding PC exis-
tence, lesion size, and localization served as Gold
Standard.
Statistical analyses
Radiological and surgical PCI scores were compared to
each other applying the Spearman correlation coefficient
to measure inter-rater reliability. Inter-observer reliabil-
ity between two radiological readings was also analyzed
using the Spearman correlation coefficient. Intra-obser-
ver reliability between the two readings of the same
radiologist was measured using the intra-class correla-
tion coefficient ("ICC”). All correlations were tested for
statistical significance using the p-value. Different PCI
scores were also evaluated for statistical difference
applying the Wilcoxon rank test. In addition to correla-
tion coefficients, both, sensitivities and specificities were
calculated for the individual abdominal regions as well
as lesion size. Statistical analyses were performed using
Excel software with Analyse-IT statistical package.
Figure 1 The Sugarbaker’s Peritoneal Cancer (PCI) describes the involvement of abdominal tumor mass., [21].
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Differences in PCI results for intra-operative and
radiological diagnosis
PCI observations of 37 intra-operative procedures con-
ducted by a single surgeon are compared with indepen-
dent PCI observations of two radiologists. Key findings
are high levels of correlation between the intra-operative
and radiological observations showing correlation coeffi-
cients of around 0.9. In particular, compared to intra-
operative findings, Radiologist 1 shows correlations of
0.930 (Figure 2) and 0.888 for his first and second read-
ing, respectively. Radiologist 2 shows a correlation of
0.887.
All correlation coefficients in Table 1 is statistically
significant at p-values below 0.001. In order to assess
the reliability of findings, the intra and inter-rater reli-
abilities of observations by Radiologist 1 and Radiologist
2w e r ee x a m i n e d .R e s u l t sf o rintra-rater reliability of
Radiologist 1 first and second reading show high levels
of reliability indicated by an intra-class correlation coef-
ficient ("ICC”) of 0.909 (p-value < 0.001). Correlation
coefficients of 0.913 and 0.953 between readings of
Radiologist 1 and Radiologist 2 demonstrate high inter-
rater reliability.
Sensitivity and specificity between Radiologist 1 (first
reading) and the Gold Standard are 94% and 80%,
respectively (Table 2). Specificities are consistent for the
other two radiological readings at 80% as both radiolo-
gists correctly detected 4 patients without PC (i.e., with-
o u ta ni n t r a - o p e r a t i v eP Cf i n d i n g )b u to b s e r v e d1f a l s e
positive for the same patient without PC. However, for
this fifth patient without PC, PCI scores are PCI = 2
with 2 regions of LS = 1 for the first reading of Radiolo-
gist 1, PCI = 10 with 8 regions of LS = 1 and 1 region
of LS = 2 for the second reading of Radiologist 1, as
w e l la sP C I=7w i t h7r e g i o n so fL S=1f o rt h ef i r s t
reading of Radiologist 2. This demonstrates that the
false positives were assigned small lesion sizes. The sen-
sitivity for the second reading of Radiologist 1 is 94%
corresponding to his first reading although true positives
and/or false negatives are different by one patient. Radi-
ologist 2 shows a sensitivity of 97% (Table 2).
In most relations, the Wilcoxon rank test, used to
analyze differences among the intra-operative observa-
tions and radiologist observations, indicates statistically
insignificant differences at p-values > 0.05 (Table 3).
In light of high levels of correlation between intra-
operative and radiological observations the insignifi-
cantly different recorded findings suggest that both radi-
ologists evaluated the magnitude of PCI insignificantly
differently than the surgeon (i.e. Gold Standard).
CT analysis by abdominopelvic regions
Correlation analyses by abdominopelvic region were
conducted between the intra-operative findings (Gold
Standard) and the first reading of Radiologist 1. Results























PCI - Radiologist  1
Comparison of PCIs between Surgeon and Radiologist  1
Figure 2 Correlation 0.930 (p < 0.05) between radiological PCI and surgical PCI.
Table 1 Overview of correlation coefficients.
Radiologist 1 Radiologist 2
1st Reading 2nd Reading
Intra-operative 0,930 0,888 0,887
Intra-rater Reliability:
1st Reading Radiologist 1 0,909
Inter-rater Reliability:
1st Reading Radiologist 1 0,953
2nd Reading Radiologist 1 0,913
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value < 0.05) (Table 4).
The analysis of results shows relatively higher correla-
tions in the upper and middle abdominopelvic regions
compared to the lower region and the smaller bowel.
However, the upper and middle abdominopelvic regions
show lower sensitivity and specificity at 86% and 73%,
respectively, compared to the lower abdominopelvic
region. This result suggests a relatively high CT perfor-
mance. CT performance in the smaller bowel is inferior
with lower levels of correlation and levels of sensitivity
below 0.6 and 70%, respectively (Figure 3).
CT performance is high in the middle abdominopelvic
regions which have more evenly distributed lesions sizes
of 1, 2, and 3 compared to the upper region with a con-
centration around lesion size 1 (Table 5).
Differences in results by abdominopelvic region appear
to be due to different lesion sizes (excepted for small
bowel evaluation) and not because of anatomic or
pathologic differences.
Analysis by lesion size
Analysis of findings by lesion size show that results
depend on lesion size and that sensitivities are improved
with increasing lesion sizes but matching observations
(defined as the number of correct radiological tumor
size observations divided through the number of total
observations) show a declining rate (Table 6).
While sensitivities increase from 74% for LS = 1 to
90% for LS = 3 with a peak at LS = 2 of 97%, the pro-
portion of actually matching observations between the
Gold Standard and Radiologist 1 declines from 84% for
LS = 0 to 34% for LS = 3.
Discussion
PC is a metastasis derived from different primary
tumors such as the ovarian, the abdominal, and the col-
orectal carcinomas (in order of highest frequency). In
many cases, a progressed stadium of tumor can be
observed in connection with diagnosed PC and is often
associated with a negative prognosis. The survival rate
of patients with peritoneal metastases from colorectal
origin is low with 5 to 32 months [24].
Several treatment methods exist for the therapy of PC.
A multimodal treatment procedure introduced in 1990
is commonly used including cytoreductive surgery with
subsequent intra-abdominal and intra-peritoneal
hypothermic chemotherapy. This treatment procedure
allows a 5 year survival rate of 30% to 45% [25].
The outcomes of PC diagnosis and prognosis are pri-
marily dependent on the parameters of tumor spread,
localization, and lesion size. Exact determinations of
these parameters is therefore of clinical importance for
determining and improving common prognosis and
therapy planning. In clinical practice it is of importance
to decide which therapy regime to choose, and it is
furthermore important to find out if a patient has to be
excluded from a certain therapy regime or not. Patients
with a PCI over 20 are regarded not to be appropriate
for cytoreductive surgery ("CRS”).
Most studies were conducted with ovarian carcinoma
with primary tumor. Further studies with patients with
PC of non-gynecological origin such as the colorectal
carcinoma would be of clinical interest.
In our study the correlation between radiological and
intra-operative finding is very high with a correlation
coefficient around 0.9. All correlations were statistically
significant at p-values below 0.001.
Notable are correlation coefficients of single regions
that are below 0.900 and range between 0.418 and 0.881
compared to an overall PCI correlation of 0.930. This
suggests that the PCI, as summation of the observations
in the 13 regions, could be misleading due to its aggre-
gating effect. Through this summation, potential indivi-
dual differences in observations could compensate each
other leading to an overall lower PCI difference.
Table 2 Overview of sensitivites and specificities of
Radiologist 1 and Radiologist 2.
Radiologist 1 Radiologist 2
1st Reading 2nd Reading
True positives 30 30 31
False negatives 2 2 1
Sensitivity 94% 94% 97%
True negatives 4 4 4
False positives 1 1 1
Specificity 80% 80% 80%
PPV 97% 97% 97%
NPV 67% 67% 80%
Table 3 Significance of difference in results demonstrated with the Wilcoxon rank test (p-Value).
Significance of difference in results
First Reading Second Reading Reading
Wilcoxon rank test (p-Value) Radiologist 1 Radiologist 1 Radiologist 2
Intra-operative (surgeon) 0,35 0,42 0,02
First Reading Radiologist 1 0,66 0,02
Second Reading Radiologist 1 0,08
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nopelvic regions is shown in Table 5.
Evaluations of the PCI Scores are depending on the
expertise and experience of the radiologist and surgeon.
For this reason another independent reading of the CT
scans by a second radiologist was included in this study.
We measured a high inter rater reliability between both
radiologists of 0.953 and 0.913 at p values below 0.001.
Furthermore, to assess the reliability of findings one
radiologist evaluated CT scans a second time. The intra-
rater reliability supported by in the intra class coefficient
amounted to 0.909 (p < 0.001) which could be consid-
ered very high.
This study shows that both radiologists with a similar
background of experience evaluated CT scans with high
levels of correlation. These finding are in line with other
recent published studies.
In a study by Coakley et al. in which preoperative CT
scans of patients with ovarian carcinoma were reviewed
by three independent readers, showed that the depiction
of peritoneal metastases is good to excellent [3]. The
Kappa value in his study ranged between 0.75 to 0.91
which indicates good to excellent inter-observer
agreements.
This study shows an overall sensitivity of 94% and
specificity of 80% which are broadly in line with more
recent studies. Studies by Coakley et al. and Tempany et
al. showed sensitivities of 85% to 93% in the detection
of peritoneal metastases in patients with ovarian cancer
[3,26].
Table 4 Results by abdominopelvic region including correlation coefficient, p-value, sensitivity, specificity,
underestimation, and overestimation.
Abdominopelvic region
Upper Middle Lower Small Bowel
1238047659 1 0 1 1 1 2
Correlation 0,748 0,713 0,660 0,823 0,774 0,881 0,659 0,726 0,698 0,418 0,431 0,519 0,533
P-value 0,000 0,000 0,000 0,000 0,000 0,000 0,000 0,000 0,000 0,010 0,008 0,001 0,001
Sensitivity 86% 86% 91% 96% 86% 100% 96% 88% 93% 50% 53% 70% 70%
Specificity 87% 75% 73% 79% 75% 94% 62% 69% 80% 89% 94% 100% 100%
Under estimated 14% 14% 9% 4% 14% 0% 4% 13% 7% 50% 47% 30% 30%
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Figure 3 Analyses of abdominopelvic regions including correlation, sensitivity and specificity.
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ranging from 0.418 to 0.881 at statistically significant
levels. Higher correlations were found in upper and
middle abdominopelvic regions compared to lower
region and small bowel. Upper and middle abdomino-
pelvic regions show higher sensitivities and specificities
above 86% and 73%, respectively, compared to the lower
region.
The best evaluated regions were left flank (4) with
1 0 0 %s e n s i t i v i t y ,r i g h tl o w e r( 7 )a n dr i g h tf l a n k( 8 )
with 96% and left lower (5) with 93%. The inclusion
of the smaller bowel plays an important part in the
prognosis and a reason for including it in this study
regarding tumor extent and size. In line with finding
in previous studies, CT is less appropriate for diagnos-
ing the small bowel region. In this region, results
show the lowest sensitivities in this study of 50% to
70% and correlation levels between 0.418 and 0.533.
The study by Koh et al. shows sensitivities of 8% to
14% in the small bowel region which can also be
f o u n di nas t u d yb yd eB r e eet al. [4,14]. The improve-
ment of sensitivities in this study is expected to be a
result of the application of a single center setup with
a highly standardized CT acquisition protocol.
Furthermore CT scans in this study were performed
with oral and intravenous fillings and reconstruction.
It seems probable that a standardized CT acquisition
protocol leads to better results in detection rates. A
possible reason for low sensitivity in the detection of
PC diseases could be the time lag between the CT
scan and the operative surgery during which period a
tumor can potentially grow. These results observations
are supported by high correlations between radiologi-
cal and surgical findings and high levels of inter and
intra-rater reliability.
The relatively lower performance of CT in the upper
region can be explained by a concentration of lesions
sizes of 1 where CT shows a low sensitivity. Low sensi-
tivity and high specificity in the small bowel could stem
from a high concentration of lesion sizes of 1 and 0,
respectively.
It is shown that the PCI score is depending on lesion
size. With increasing lesion size the sensitivity is
improving; however, accurate observations are declining
with increasing lesion size. Sensitivity increases from
7 4 %f o rL S=1t o9 0 %f o rL S=3 ,w h i l et h ea c c u r a c y
between surgical and radiological observations is declin-
ing from 84% for LS = 1 to 34% for LS = 3. A declining
accuracy with an increasing lesion size is explained by
increasing underestimation by the radiologist. It is
observed that the radiologist systematically underesti-
mates the Gold Standard which is supported by the
findings according to lesion size.
There exist several methods for imaging PC including
CT, magnet resonance tomography, FDG-PET-Observa-
tion, or ultrasound. The most used and commonly
applied method is the CT based diagnosis. Subject of
this study is the assessment of appropriateness and
accuracy of CT for the detection and diagnosis of PC.
Due to comparatively higher availability, lower costs,
and evaluation artifacts of bowel peristaltic and breath-
ing, CT with oral or intravenous contrast injection is
still the most commonly used method for the diagnosis
of PC [27].
Table 5 Distribution of lesion sizes in the various abdominopelvic regions.
Abdominopelvic region
Upper Middle Lower Small Bowel
Lesion size 1 2 3 80476591 0 1 1 1 2
LS = 0 15 16 15 14 16 16 13 13 10 19 18 17 17
LS = 1 11 12 14 8 5 10 9 10 15 14 16 18 17
L S = 2 6448771 1 1 1 73212
L S = 3 5547944351111
LS = 0 41% 43% 41% 38% 43% 43% 35% 35% 27% 51% 49% 46% 46%
LS = 1 30% 32% 38% 22% 14% 27% 24% 27% 41% 38% 43% 49% 46%
LS = 2 16% 11% 11% 22% 19% 19% 30% 30% 19% 8% 5% 3% 5%
LS = 3 14% 14% 11% 19% 24% 11% 11% 8% 14% 3% 3% 3% 3%
Table 6 Analysis of findings by lesion size demonstrating
true positives, false negatives, sensitivity, specificity,
accuracy, underestimation, overestimation.
LS = 0 LS = 1 LS = 2 LS = 3
Region count 199 159 73 50
True positives n.a. 118 71 45
False negatives n.a. 41 2 5
Sensitivity n.a. 74% 97% 90%
Specificity 84% n.a. n.a. n.a.
Accuracy 84% 53% 48% 34%
Under estimate n.a. 26% 34% 66%
Over estimate 16% 21% 18% n.a.
n = 481 (37 patients × 13 abdominopelvic regions)
n.a. = not available
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priateness of CT for the detection of PC, sensitivities
reach from 14% to 93% and specificities from 54% to
100%. Such spectrums are expected to be the result of
the advent of new technology including the multi-detec-
tor-CT or the multimodal reconstruction. The recent
study by Coakley et al. showed sensitivities of 85% to
93% and specificities of 91% to 96% for CT based PC
diagnosis [3].
The increasing improvement of results could be due
to the further development of technology such as the
contrast enhanced spiral CT. In a study by Jacquet et al.
sensitivities were first described in relation to tumor
lesion size; sensitivities were recorded at 70% for a max-
imum lesion size of 2 cm whereas at 28% for lesion
sizes of less than 0.5 cm [22].
Coakley et al. investigated sensitivities in relation to
lesion size and showed 25% to 50% lower sensitivities
for lesion sizes below 1 cm compared to overall
observed sensitivities between 85% and 93%, thereby
suggesting lower performance of CT for small lesion
sizes [3]. Further studies investigating CT performance
for small lesion sizes would be of clinical interest.
The study by Tempany et al. investigated sensitivities
in relation to origin of primary tumor; sensitivity of 92%
was observed with patients with ovarian carcinoma [26].
Similarly, the study by de Bree et al. showed a sensitivity
of 60% to 76% for patients with appendenix and colorec-
tal carcinoma [20]. In most studies sensitivities were
below 20% for the regions of mesenterium and small
bowel [14]. According to de Bree et al. the surface can
best be observed with the existence of ascites [20]. In
this study the existence of ascites did not explain signifi-
cantly better results.
With the introduction of more advanced technologies
imaging quality has been improved. Coronary and sagit-
tal imaging methods result in the detection of smaller
tumor lesion sizes with smaller artifacts [28]. With the
advent of higher resolutions of scanner improved depic-
tion of PC could expected.
A disadvantage of CT is the distinguishing of the
tumor scar tissue from the post-operative scar tissue
which is almost impossible with current sophistication
of CT technology.
A study by Franiel et al. investigated the impact of
thinner layers and multi-planar reconstruction in con-
nection with the observation of PC [29]. Layers of 5 mm
thickness were found to be sufficient whereas layers of 1
mm in connection with MPR could improve sensitivities
and diagnostic confidence. There, results were depen-
dent on the radiologist’s years of experience. A radiolo-
gist with over 10 years of experience, using 0 coronal
and sagittal MPRs, could achieve an improved sensitivity
o f9 6 %w h e nu s i n g1m mt h i ns l i c e sc o m p a r e dt o8 6 %
when using 0.5 cm thin slices. Best results with sensitiv-
ities of up to 100% could be shown by using MPRs.
MRI and spiral CT show similar accuracy in the
detection of PC and PC size, spread and localization
compared to CT. In a study by Kim et al. it is showed
that MRI achieves a sensitivity of 95% [30]. The manda-
tory long hold of breath proves to be difficult for many
patients with tumors due to their generally weak condi-
tion. This could lead to evaluation artifacts and diminish
the quality of MRI depiction [30]. Another disadvantage
is the existence of ascites which could also lead to arti-
facts using MRI and could often be the reason for high
wrong positive-rates [30].
Tempany et al. in his study investigated MRI in com-
parison to CT wherein higher sensitivities for MRI of
95% compared to 92% for CT could be shown [26].
However, specificities were lower at 80% for MRI com-
pared to 82% for CT. Overall the accuracy was not sig-
nificantly different between the two modalities.
Although MRI performed better at sensitivities between
85% to 90% for small modular peritoneal changes of less
than 1 cm compared to CT with 25% to 50% it could
questionable whether MRI is a superior imaging method
given its relatively longer duration of observation and
lower availability. In previous literature, the sensitivity of
MRI for the detection of PC is approximately 85%
[31,32] and specificity of around 80% [26].
The appropriateness and effectiveness of PET-CT for
the diagnosis of PC has yet to be investigated. The study
by Dromain et al. concludes that neither CT nor PET-
CT could be used stand-alone for the prognosis and
planning of PC therapy due to a correct detection eva-
luation of 70% for CT and 80% for PET-CT [33].
The FDG-PET (2-Fluor-2-deoxy-D-Glucose positron
emission tomography) is another alternative method but
showed low specificities between 54% and 86% [34,35].
FDG-PET also shows lower accuracy for the detection
of smaller lesion sizes compared to MRT und CT [36].
The laparotomy is still the preferred method for the
exact staging of investigation with histological biopsy. It
is, however, also associated with peri-operative dissemi-
nation of maligned cells. Furthermore, the invasive pro-
cedure is often associated with higher rates of mortality
and morbidity [37-39].
Laparoscopy is also an effective method for staging
peritoneal carcinomatosis. Unfortunately, not every
region can be assessed. Therefore, laparoscopy appears
to be a highly suitable method of diagnosis for the small
bowel in cases of vague involvement.
In line with previous research, this study underpins
that CT is an effective imaging modality for the pre and
postoperative staging of patients. A standardized CT
acquisition protocol in a certified PC center and read-
ings performed by highly experienced radiologists could
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Page 8 of 10result in sufficiently high sensitivity and specificity rates
for an effective patient selection process. Relatively high
sensitivities and specificities results are achieved by
abdominopelvic region as well as by lesion size. How-
ever, the appropriateness of CT for the evaluation of the
small bowel region is still insufficient and needs to be
further investigated.
Conclusion
A standardized CT acquisition protocol in a certified
peritoneal cancer center and readings performed by
highly experienced radiologists seem to achieve higher
values for sensitivity and specificity and therefore are
expected to result in a more effective patient selection
process.
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